Intermittent Therapy in Metastatic Renal Cell Carcinoma Patients Treated With Ipilimumab and Nivolumab
Clinical trial NCT03126331 · COMPLETED
Trial details
- NCT number
- NCT03126331
- Sponsor
- Case Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2023-10-24
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.